Longevity & Anti-Aging Medicine

Hormone Replacement Therapy (HRT)

HGH, Sermorelin, Testosterone and HCG Treatments

Personalized and Customized Medicine

Longevity Medicine

PDL Biopharma dives after Genentech disputes Europe patents of 4 drugs, including Herceptin

Published: 14 August 2010 - Written by admin in section: Stem Cell Therapy, Stem Cells

PDL BioPharma plunges on dispute with Genentech

NEW YORK — Shares of PDL BioPharma Inc. plunged Friday on word of a royalty dispute between PDL and its collaborator Genentech.
Genentech has informed PDL that it does not believe four Genentech drugs infringe on patents held by PDL in Europe, PDL said. PDL receives royalties on sales of … Original article on : PDL Biopharma dives after Genentech disputes Europe patents of 4 drugs, including Herceptin.

«
»







Get our latest updates

Subscribe Via A Feed Reader

Recommended Resources:



Archives